# EDGAR Filing Document

**Accession Number:** 0001769628
**File Stem:** 0001769628-26-000208
**Filing Date:** 2026-4
**Character Count:** 12834
**Document Hash:** bbce7d11665a65e300aa818232192910
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001769628-26-000208.hdr.sgml**: 20260429

**ACCESSION NUMBER**: 0001769628-26-000208

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260427

**FILED AS OF DATE**: 20260429

**DATE AS OF CHANGE**: 20260429

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** McBee Brannin
- **CENTRAL INDEX KEY:** 0002058103

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42563
- **FILM NUMBER:** 26919421

**MAIL ADDRESS:**
- **STREET 1:** C/O COREWEAVE, INC.
- **STREET 2:** 290 WEST MT. PLEASANT AVENUE, SUITE 4100
- **CITY:** LIVINGSTON
- **STATE:** NJ
- **ZIP:** 07039
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CoreWeave, Inc.
- **CENTRAL INDEX KEY:** 0001769628
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-PREPACKAGED SOFTWARE [7372]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 823060021
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 290 W. MT. PLEASANT AVENUE, SUITE 4100
- **CITY:** LIVINGSTON
- **STATE:** NJ
- **ZIP:** 07039
- **BUSINESS PHONE:** (973) 270-9737

**MAIL ADDRESS:**
- **STREET 1:** 290 W. MT. PLEASANT AVENUE, SUITE 4100
- **CITY:** LIVINGSTON
- **STATE:** NJ
- **ZIP:** 07039

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Atlantic Crypto Corp
- **DATE OF NAME CHANGE:** 20190304

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[x] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>McBee Brannin<br><sub>(Last) (First) (Middle)</sub><br>C/O COREWEAVE, INC.<br>290 WEST MT. PLEASANT AVENUE, SUITE 4100<br><sub>(Street)</sub><br>LIVINGSTON, NJ 07039<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2026-04-27 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Chief Development Officer_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>CoreWeave, Inc. [ CRWV ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Class A Common Stock | 2026-04-27 |  | C |  | 33350 | A | <sup>(1)</sup> | 33350 | I | Canis Major 2025 GRAT<sup>(2)</sup> |
| Class A Common Stock | 2026-04-27 |  | S<sup>(3)</sup> |  | 2667 | D | 105.6104<sup>(4)</sup> | 30683 | I | Canis Major 2025 GRAT<sup>(2)</sup> |
| Class A Common Stock | 2026-04-27 |  | S<sup>(3)</sup> |  | 3683 | D | 106.57<sup>(5)</sup> | 27000 | I | Canis Major 2025 GRAT<sup>(2)</sup> |
| Class A Common Stock | 2026-04-27 |  | S<sup>(3)</sup> |  | 9242 | D | 107.4854<sup>(6)</sup> | 17758 | I | Canis Major 2025 GRAT<sup>(2)</sup> |
| Class A Common Stock | 2026-04-27 |  | S<sup>(3)</sup> |  | 1889 | D | 108.6159<sup>(7)</sup> | 15869 | I | Canis Major 2025 GRAT<sup>(2)</sup> |
| Class A Common Stock | 2026-04-27 |  | S<sup>(3)</sup> |  | 1486 | D | 109.5086<sup>(8)</sup> | 14383 | I | Canis Major 2025 GRAT<sup>(2)</sup> |
| Class A Common Stock | 2026-04-27 |  | S<sup>(3)</sup> |  | 4850 | D | 110.7696<sup>(9)</sup> | 9533 | I | Canis Major 2025 GRAT<sup>(2)</sup> |
| Class A Common Stock | 2026-04-27 |  | S<sup>(3)</sup> |  | 7845 | D | 111.426<sup>(10)</sup> | 1688 | I | Canis Major 2025 GRAT<sup>(2)</sup> |
| Class A Common Stock | 2026-04-27 |  | S<sup>(3)</sup> |  | 1688 | D | 112.1269<sup>(11)</sup> | 0 | I | Canis Major 2025 GRAT<sup>(2)</sup> |
| Class A Common Stock | 2026-04-27 |  | C |  | 12500 | A | <sup>(1)</sup> | 12500 | I | Canis Minor 2025 GRAT<sup>(12)</sup> |
| Class A Common Stock | 2026-04-27 |  | S<sup>(3)</sup> |  | 1000 | D | 105.6104<sup>(4)</sup> | 11500 | I | Canis Minor 2025 GRAT<sup>(12)</sup> |
| Class A Common Stock | 2026-04-27 |  | S<sup>(3)</sup> |  | 1380 | D | 106.57<sup>(5)</sup> | 10120 | I | Canis Minor 2025 GRAT<sup>(12)</sup> |
| Class A Common Stock | 2026-04-27 |  | S<sup>(3)</sup> |  | 3464 | D | 107.4853<sup>(6)</sup> | 6656 | I | Canis Minor 2025 GRAT<sup>(12)</sup> |
| Class A Common Stock | 2026-04-27 |  | S<sup>(3)</sup> |  | 708 | D | 108.6154<sup>(7)</sup> | 5948 | I | Canis Minor 2025 GRAT<sup>(12)</sup> |
| Class A Common Stock | 2026-04-27 |  | S<sup>(3)</sup> |  | 557 | D | 109.5082<sup>(8)</sup> | 5391 | I | Canis Minor 2025 GRAT<sup>(12)</sup> |
| Class A Common Stock | 2026-04-27 |  | S<sup>(3)</sup> |  | 1818 | D | 110.7694<sup>(9)</sup> | 3573 | I | Canis Minor 2025 GRAT<sup>(12)</sup> |
| Class A Common Stock | 2026-04-27 |  | S<sup>(3)</sup> |  | 2941 | D | 111.4261<sup>(10)</sup> | 632 | I | Canis Minor 2025 GRAT<sup>(12)</sup> |
| Class A Common Stock | 2026-04-27 |  | S<sup>(3)</sup> |  | 632 | D | 112.1265<sup>(11)</sup> | 0 | I | Canis Minor 2025 GRAT<sup>(12)</sup> |
| Class A Common Stock |  |  |  |  |  |  |  | 54000 | I | Canis Major SM Trust<sup>(13)</sup> |
| Class A Common Stock |  |  |  |  |  |  |  | 1800 | I | See Footnote<sup>(14)</sup> |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Class B Common Stock | <sup>(1)</sup> | 2026-04-27 |  | C |  |  | 33350 | <sup>(1)</sup> | <sup>(1)</sup> | Class A Common Stock | 33350 | <sup>(1)</sup> | 3917227 | I | Canis Major 2025 GRAT<sup>(2)</sup> |
| Class B Common Stock | <sup>(1)</sup> | 2026-04-27 |  | C |  |  | 12500 | <sup>(1)</sup> | <sup>(1)</sup> | Class A Common Stock | 12500 | <sup>(1)</sup> | 561205 | I | Canis Minor 2025 GRAT<sup>(12)</sup> |
| Class B Common Stock | <sup>(1)</sup> |  |  |  |  |  |  | <sup>(1)</sup> | <sup>(1)</sup> | Class A Common Stock | 324000 |  | 324000 | I | Canis Major 2024 Irrevocable Trust LLC<sup>(15)</sup> |
| Class B Common Stock | <sup>(1)</sup> |  |  |  |  |  |  | <sup>(1)</sup> | <sup>(1)</sup> | Class A Common Stock | 108600 |  | 108600 | I | Canis Major 2025 Family Trust LLC<sup>(16)</sup> |
| Class B Common Stock | <sup>(1)</sup> |  |  |  |  |  |  | <sup>(1)</sup> | <sup>(1)</sup> | Class A Common Stock | 1582773 |  | 1582773 | I | Canis Major 2026 GRAT<sup>(2)</sup> |
| Class B Common Stock | <sup>(1)</sup> |  |  |  |  |  |  | <sup>(1)</sup> | <sup>(1)</sup> | Class A Common Stock | 122000 |  | 122000 | I | Canis Minor 2025 Family Trust LLC<sup>(17)</sup> |
| Class B Common Stock | <sup>(1)</sup> |  |  |  |  |  |  | <sup>(1)</sup> | <sup>(1)</sup> | Class A Common Stock | 263795 |  | 263795 | I | Canis Minor 2026 GRAT<sup>(12)</sup> |

---

### Footnotes:

(1) Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation.

(2) The reported securities are directly held by a grantor retained annuity trust, of which the reporting person is the sole trustee and beneficiary.

(3) The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025.

(4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.02 to $105.97, inclusive.

(5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.02 to $107.01, inclusive.

(6) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.02 to $108.01, inclusive.

(7) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.02 to $108.93, inclusive.

(8) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.02 to $109.995, inclusive.

(9) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.03 to $111.02, inclusive.

(10) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.03 to $112.02, inclusive.

(11) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.03 to $112.76, inclusive.

(12) The reported securities are directly held by a grantor retained annuity trust, of which the reporting person's spouse is the sole beneficiary and trustee.

(13) The reported securities are directly held by the Canis Major SM Trust  (the "Canis Trust"), an irrevocable trust with a third-party trustee, of which the reporting person's minor child is beneficiary.  The reporting person has the power to remove and replace the Canis Trust's trustee.

(14) The reported securities are directly held of record by the reporting person's child.

(15) The reported securities are directly held by the Canis Major 2024 Irrevocable Trust LLC of which the reporting person serves as manager.

(16) The reported securities are directly held by the Canis Major 2025 Family Trust LLC, of which the reporting person serves as manager.

(17) The reported securities are directly held by the Canis Minor 2025 Family Trust LLC, of which the reporting person serves as manager.

**Remarks:**
This Form 4 is Part 2 of 2 for this reporting person. Transactions by the reporting person are continued on this Part 2.

**Signature:** /s/ Nisha Antony, as Attorney-in-Fact  
**Date:** 2026-04-29

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**